Drugs / Autologous Stromal Vascular Fraction (SVF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02145897 | Aug 2014 → Aug 2015 | limb ischemia | Kasiak Research Pvt. Ltd. | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Stromal Vascular Fraction (SVF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02145897 ↗ |
| Known as | Autologous Stromal Vascular Fraction | “Autologous Stromal Vascular Fraction” NCT02145897 ↗ |
| Modality | Cell therapy | “adipose derived Stromal Vascular Fraction (SVF)” NCT02145897 ↗ |
| Route | Intramuscular | “infused intravenously and intramuscularly” NCT02145897 ↗ |
| Route | Intravenous | “infused intravenously and intramuscularly” NCT02145897 ↗ |